Chen YB - Search Results

1

[Effects of arsenic trioxide on cell cycle and expression of cyclin dependent kinase inhibitors of multiple myeloma cells].

Chen YB, Fu WJ, Hou J, Ding SQ, Wang DX, Yuan ZG, Kong XT. Chen YB, et al. Zhonghua Xue Ye Xue Za Zhi. 2003 Apr;24(4):193-6. Zhonghua Xue Ye Xue Za Zhi. 2003. PMID: 12864950 Chinese.

2

[Detection of IgH-MMSET fusion gene in multiple myeloma patients and its significance].

Jiang H, Hou J, Chen YB, Ding SQ. Jiang H, et al. Among authors: chen yb. Zhonghua Xue Ye Xue Za Zhi. 2003 Oct;24(10):515-8. Zhonghua Xue Ye Xue Za Zhi. 2003. PMID: 14690579 Chinese.

3

[Mechanism of arsenic trioxide-induced cytotoxicity on multiple myeloma cells].

Chen YB, Hou J, Fu WJ, Ding SQ, Wang DX, Yuan ZG, Kong XT. Chen YB, et al. Ai Zheng. 2003 Dec;22(12):1276-9. Ai Zheng. 2003. PMID: 14693051 Chinese.

4

[Prognostic analysis and assessment on the clinical staging systems of multiple myeloma--a report of 206 cases].

Tao ZF, Fu WJ, Chen YB, Yuan ZG, Wang DX, Hou J. Tao ZF, et al. Among authors: chen yb. Ai Zheng. 2006 Apr;25(4):461-4. Ai Zheng. 2006. PMID: 16613681 Chinese.

5

Prognostic factors for the efficacy of thalidomide in the treatment of multiple myeloma: a clinical study of 110 patients in China.

Li Y, Hou J, Wang D, Fu W, Yuan Z, Chen Y, Tao Z. Li Y, et al. Leuk Lymphoma. 2006 Dec;47(12):2593-600. doi: 10.1080/10428190600955753. Leuk Lymphoma. 2006. PMID: 17169804

6

[Bortezomib in combination with dexamethasone for the treatment of relapsed or refractory multiple myeloma].

Yuan ZG, Hou J, Zhou F, Fu WJ, Chen YB, Xi H, Yang SL. Yuan ZG, et al. Among authors: chen yb. Zhonghua Xue Ye Xue Za Zhi. 2006 Oct;27(10):653-5. Zhonghua Xue Ye Xue Za Zhi. 2006. PMID: 17343194 Chinese.

7

[The effect of cyclin D2 shRNA on the proliferation and apoptosis of LP-1 cell].

Guo C, Hou J, Chen YB, Jin HY, Fu WJ, Yuan ZG, Wang DX. Guo C, et al. Among authors: chen yb. Zhonghua Xue Ye Xue Za Zhi. 2006 Oct;27(10):666-9. Zhonghua Xue Ye Xue Za Zhi. 2006. PMID: 17343197 Chinese.

8

Polymorphisms of CYP2C19 gene are associated with the efficacy of thalidomide based regimens in multiple myeloma.

Li Y, Hou J, Jiang H, Wang D, Fu W, Yuan Z, Chen Y, Zhou L. Li Y, et al. Haematologica. 2007 Sep;92(9):1246-9. doi: 10.3324/haematol.11319. Epub 2007 Aug 1. Haematologica. 2007. PMID: 17666363 Free article.

9

Prognostic factors and staging systems of multiple myeloma:

Tao ZF, Fu WJ, Yuan ZG, Wang DX, Chen YB, Hou J. Tao ZF, et al. Among authors: chen yb. Chin Med J (Engl). 2007 Oct 5;120(19):1655-8. Chin Med J (Engl). 2007. PMID: 17935664

10

[Efficacy of thalidomide combined dexamethasone on newly diagnosed multiple myeloma].

Yuan ZG, Hou J, Wang DX, Fu WJ, Chen YB, Xi H. Yuan ZG, et al. Among authors: chen yb. Ai Zheng. 2007 Dec;26(12):1369-72. Ai Zheng. 2007. PMID: 18076804 Free article. Clinical Trial. Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,259 results

Search Page

Filters